Seaflower Ventures Overview

  • Investor Type
  • Venture Capital

  • Status
  • Inactive

  • Investments
  • 23

  • Exits
  • 9

Exits

Seaflower Ventures General Information

Company Description

Seaflower Ventures was a venture capital firm headquartered in Waltham, Massachusetts. The firm preferred to invest in the bio-pharmaceuticals, therapeutics and development, biotechnology, e-pharma and medical devices sectors.

Business Details

Year Founded
1993
Investor Status
Out of Business
Primary Investor Type
Venture Capital
Corporate Office
  • 1000 Winter Street
  • Bay Colony Corporate Center, Suite 1000
  • Waltham, MA 02451
  • United States

Seaflower Ventures Investments (23)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Serenex 28-Jun-2007 Later Stage VC 0000 Discovery Tools (Healthcare) Profitable
Targanta Therapeutics 12-Feb-2007 00000 00000 000.00 Pharmaceuticals Generating Revenue 000000000 0000
BioValve Technologies 05-Sep-2006 00000 00000 00.00 Medical Supplies Out of Business
RenaMed Biologics 24-Aug-2006 00000 00000 000.00 Therapeutic Devices Out of Business
Serenex 07-Oct-2005 00000 00000 000.00 Discovery Tools (Healthcare) Profitable
RenaMed Biologics 01-Jun-2005 00000 00000 000.00 Therapeutic Devices Out of Business
Azelon Pharmaceuticals 18-May-2005 00000 00000 0000 Drug Discovery Out of Business 000000000 0000
Azelon Pharmaceuticals 05-Oct-2004 00000 00000 000.00 Drug Discovery Out of Business 000000000 0000
Sopherion 23-Sep-2004 Early Stage VC 0000 Discovery Tools (Healthcare) Out of Business
RenaMed Biologics 01-Jul-2004 Later Stage VC 000.00 Therapeutic Devices Out of Business
You’re viewing 10 of 23 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Seaflower Ventures Exits (9)

Company Name Exit Date Exit Type Exit Size
BioValve Technologies 01-Sep-2014 Bankruptcy: Liquidation
RenaMed Biologics 01-Aug-2014 0000000000: 000000
Azelon Pharmaceuticals 01-Jan-2013 0000000000: 000000
Veritas Medicine 08-Apr-2008 000000000000000000
Serenex 01-Apr-2008 000000000000000000 00000
Targanta Therapeutics 10-Oct-2007 000 000.00
endoVia Medical 14-Apr-2005 000000000000000000
Anvil (Vertical Market Software) 20-Aug-2004 Bankruptcy: Liquidation
Sopherion Buyout/LBO
To view Seaflower Ventures’s complete exits history, request access »

Seaflower Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Seaflower Ventures FAQs

  • What is Seaflower Ventures?

    Seaflower Ventures was a venture capital firm headquartered in Waltham, Massachusetts.

  • When was Seaflower Ventures founded?

    Seaflower Ventures was founded in 1993.

  • Who is the founder of Seaflower Ventures?

    Alexander Moot is the founder of Seaflower Ventures.

  • Where is Seaflower Ventures headquartered?

    Seaflower Ventures is headquartered in Waltham, MA.

  • How many investments has Seaflower Ventures made?

    Seaflower Ventures has made 23 investments.

  • What has Seaflower Ventures invested in?

    Seaflower Ventures has made numerous investments in companies like Serenex, Targanta Therapeutics, and BioValve Technologies within the Discovery Tools (Healthcare), Pharmaceuticals, and Medical Supplies industries.

  • What has Seaflower Ventures invested in recently?

    Seaflower Ventures's latest investment was on 28-Jun-2007 in Serenex, a company within the Discovery Tools (Healthcare) industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »